Fampridine April 12, 2017 Fampridine Trade Name Neurelan Orphan Indication Chronic, incomplete spinal cord injury USA Market Approval USA USA Designation Date 1997-06-02 00:00:00 Sponsor Acorda Therapeutics, Inc.;15 Skyline Dr.;Hawthorne, New York, 10532
